<DOC>
	<DOCNO>NCT01015404</DOCNO>
	<brief_summary>This study aim investigate safety use Trafermin ( recombinant human basic fibroblast growth factor ) periodontal surgery .</brief_summary>
	<brief_title>A Study Assess Safety Using Fibroblast Growth Factor-2 With Periodontal Surgery Japan ( Phase 3 )</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Vertical intrabony defect radiograph baseline Age 20 year old Using investigational drug within past 24 month Coexisting malignant tumour history Coexisting diabetes ( HbA1C 6.5 % ) Taking bisphosphonates Coexisting gingival overgrowth history</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Trafermin</keyword>
	<keyword>Periodontitis</keyword>
</DOC>